As every non-profit organization knows, it is our obligation to be purpose-driven. Most NPO founders and the people who work for them have been thrown into this space as a result of life experiences. It is our passion rather than a job to simply collect a paycheck. To access this subscriber-only content please log in […]

Cornelia Ulrich was selected to serve as vice president/president-elect of the Association of American Cancer Institute’s board of directors. Ulrich is chief scientific officer and executive director of the Comprehensive Cancer Center at Huntsman Cancer Institute at the University of Utah. To access this subscriber-only content please log in or subscribe.If your institution has a […]

A report by the American Society of Clinical Oncology points to a growing challenge in cancer care access driven by a widening gap between the number of available oncologists and increasing patient demand. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register […]

With major leadership changes, grant disruptions and terminations, and a stoked distrust in science, Steven Artandi, the director of Stanford Cancer Center, worries that young investigators will feel disenchanted by the U.S. research atmosphere and take their work and study elsewhere. To access this subscriber-only content please log in or subscribe.If your institution has a […]

In 1988, Frank McCormick learned with the rest of the field that more than 90% of patients with pancreatic cancer have a mutation in the Kirsten rat sarcoma viral gene. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored […]

Cancer care is evolving at an unprecedented pace. Practitioners feel the mounting pressures daily: rising cancer rates—particularly in younger patients—a growing population of older cancer survivors, rapid growth in new care and treatment options, and navigating heightened fiscal constraints and uncertainty. To access this subscriber-only content please log in or subscribe.If your institution has a […]

Anthony G. Letai, a physician-scientist at Harvard Medical School and Dana-Farber Cancer Institute, has been officially named the 18th director of the National Cancer Institute. To access this subscri...

The European Union, in coordination with the European Health and Digital Executive Agency, has launched DISARM, a Horizon Europe Innovation Action project that brings together 28 partners from 12 countries, including 10 EU Member States, the UK, and Canada. To access this subscriber-only content please log in or subscribe.If your institution has a site license, […]

Chris Biggar, a 34-year-old from Ohio, had just landed his dream job working in R&D when he was diagnosed with stage 4 colon cancer. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled […]

Fiscal and strategic uncertainty abound at our leading academic medical centers. Job cuts to hospital staff (University of Southern California), research nurses (Vanderbilt) and librarians (Duke) are changing the landscape of our leading centers. A decrease in the payline threatens to stall careers before they even start. In response to cuts and uncertainty, cancer center […]

The International Myeloma Foundation has announced that Heather Cooper Ortner, president & CEO of Alzheimer’s Los Angeles, and former CEO of the Dr. Susan Love Research Foundation, has been named as the IMF’s new president and chief executive officer. To access this subscriber-only content please log in or subscribe.If your institution has a site license, […]

In recent months, federal policies have stripped away funding for research on sexual and gender minoritized (SGM) communities and blocked the collection of data related to gender. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site […]

The American Lung Association launched a campaign to raise awareness about lung cancer screening and biomarker testing, shaped by the voices of people diagnosed with lung cancer and their caregivers across the country. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register […]

Chris Biggar, a 34-year-old from Ohio, had just landed his dream job working in R&D when he was diagnosed with stage 4 colon cancer. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled […]

FDA has published a new guidance for the development of non-opioid pain treatments in the Federal Register. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in sponsored accounts.Login Subscribe

On Oct. 1, for the first time in six years, the U.S. government shut down after Congress was unable to reach a deal to fund federal agencies for Fiscal Year 2026. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a […]

No description found

The National Association for Proton Therapy’s Annual Member Survey showed more patients treated, additional centers opening, and an evolving and complex case mix of disease sites being treated with proton therapy. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a […]

In recent months, federal policies have stripped away funding for research on sexual and gender minoritized (SGM) communities and blocked the collection of data related to gender. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site […]

Nearly five decades ago, I joined City of Hope’s nascent bone marrow transplant (BMT) program, which focused on improving outcomes for patients with advanced leukemia. The program had been started by Ernest Beuter and Karl Blume with the support and guidance of our colleagues in Seattle, especially Don Thomas, the 1990 Nobel laureate in medicine. […]

FDA has granted Fast Track designation to UB-VV111 for the treatment of relapsed/refractory large B-cell lymphoma following two or more lines of prior therapy and relapsed/refractory chronic lymphocytic leukemia following two or more lines of prior therapy. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in […]

Anthony G. Letai, a physician-scientist at Harvard Medical School and Dana-Farber Cancer Institute, has been officially named the 18th director of the National Cancer Institute. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are […]

On Oct. 1, for the first time in six years, the U.S. government shut down after Congress was unable to reach a deal to fund federal agencies for Fiscal Year 2026. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a […]

FDA has approved Inluriyo (imlunestrant, 200 mg tablets), an oral estrogen receptor antagonist, for the treatment of adults with estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated advanced or metastatic breast cancer whose disease progressed after at least one line of endocrine therapy. To access this subscriber-only content please log in or subscribe.If your […]